European Companies Search Engine
Registration · Managing Director: Michael Munzel, Markus Unger · Address · Capital: €25,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb10 Sept 2020 German Trade Register Announcements, Germany
Overview
Text
HRB 100882: Artemis Augenzentrum Heppenheim GmbH,
Unnamed street ??, 35683 Dillenburg, Germany
. limited liability company. Partnership agreement of 26 August 2020. Business address:
Unnamed street ??, 35683 Dillenburg, Germany
. Subject: The establishment and operation of one or more medical care centres (MVZ) in accordance with Section 95 (1) SGB V. The company is entitled to operate MVZ in different locations as (medically) independent establishments, to establish other branches, to participate in similar companies and to provide other medical services, in particular for self-payers. Share capital: EUR 25,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Appointed as Managing Director: Munzel, Michael, Essen, *??.??.????, authorized to represent one person; with the power to enter into legal transactions on behalf of the company as a representative of a third party. Appointed as Managing Director: Unger, Markus, Mannheim, *??.??.????, with the power to enter into legal transactions on behalf of the company a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: ARTEMIS Augenzentrum Heppenheim GmbH, Heppenheim (Bergstraße), Germany.
The visualizations for "Artemis Augenzentrum Heppenheim GmbH - Registration · Managing Director: Michael Munzel, Markus Unger · Address · Capital: €25,000 · Shareholder agreement · Proxy policy · Corporate Purpose"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
